With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

This trial assessed the safety and efficacy of a 25 mg dose of oral semaglutide against a placebo in 307 adults without diabetes who were either obese or overweight with at least one comorbidity.

Through the first 53 months available worldwide the Nintendo Switch is ahead of the PlayStation 5 and Xbox Series X|S. The Switch is ahead of the PS5 by 13.42 million units and is 55.93 million ...

An 8-week, multicenter, double-blind, randomized, parallel-group, forced-titration study was conducted to evaluate the antihypertensive efficacy of candesartan vs. losartan in 654 hypertensive ...

Opko Health Inc. (OPK) reported a net loss for the first quarter of 2025, with earnings per share (EPS) missing analyst expectations. The company posted an EPS of -$0.10, compared to the ...

Eli Lilly and Company (LLY) reported its first-quarter results for 2025, revealing a revenue increase of 45% compared to the same period last year, driven by strong sales of key products.

Although many daily moisturisers now boast added SPF, their effectiveness as a standalone sun protection method is debatable. The core difference lies in their formulation. While a moisturiser ...

Eli Lilly and Company (LLY) reported its first-quarter results for 2025, revealing a revenue increase of 45% compared to the same period last year, driven by strong sales of key products. The company ...